The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
Official Title: A Feasibility Study Evaluating Metabolomic and Tissue Effects of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
Study ID: NCT03285152
Brief Summary: The purpose of this study is to test any good and bad effects of an experimental diet, called a ketogenic diet, in endometrial cancer. A ketogenic diet is one that is very low in carbohydrates (simple and complex sugars). The goal of this diet is for the body to go into a state of ketosis. Ketosis is when the body does not have enough sugar for energy so it burns stored fats which create acids called ketones, which can be used for energy. Researchers hope to learn whether or not a ketogenic diet is well-tolerated and safe to eat before surgery in endometrial cancer patients.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Memorial Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up), Commack, New York, United States
Memorial Sloan Kettering Westchester (Consent & Follow Up), Harrison, New York, United States
New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau (Consent and Follow-up), Rockville Centre, New York, United States
Name: Vicky Makker, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR